Gilead Sciences Inc’s remdesivir had little or no effect on Covid-19 patients’ length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
The … [read more]

LEAVE A REPLY

Please enter your comment!
Please enter your name here